ESR1 and obesity due to melanocortin 4 receptor deficiency: This “obesity-inflammation-aromatase axis” has been proposed to play an important role in increased risk of ER+ breast cancer in postmenopausal women, by elevating estrogen levels in the breasts of women in whom levels of estrogen in the general circulation are reduced (60, 64, 65).